Antidromic vasodilatation and neurogenic inflammation

Pharmacology and Therapeutics

Volumn 37, Issue 2, 1988, Pages 275-300

  Chahl, L A ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; ELEDOISIN; PHYSALAEMIN; SUBSTANCE P; SUBSTANCE P RECEPTOR; TACHYKININ;

HUMAN; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; REVIEW; VASODILATOR NERVE;

ANIMAL; HUMAN; INFLAMMATION; NEURAL CONDUCTION; SUPPORT, NON-U.S. GOV'T; VASODILATION;

EID: 0023878860     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(88)90029-0     Document Type: Article

References (260)

1. Effects of capsaicin applied locally to adult peripheral nerve. II. Anatomy and enzyme and peptide chemistry of peripheral nerve and spinal cord
2. Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues
3. Failure of microscopic metarterioles to elicit vasodilator responses to acetylcholine, bradykinin, histamine and substance P after ischemic shock, endotoxemia and trauma: Possible role of endothelial cells
4. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
5. The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog
6. Topical capsaicin pretreatment inhibits axon reflex vasodilatation caused by somatostatin and vasoactive intestinal polypeptide in human skin
7. A VIP containing system concentrated in the lumbo-sacral region of human spinal cord
8. The substance P and adenosine triphosphate (ATP) contents of sensory nerve on degeneration
9. Modification by capsaicin and compound 48/80 of dye leakage induced by irritants in the rat
10. Asthma as an axon reflex
11. Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex
12. Enhancement of phagocytosis—A newly found activity of substance P residing in its N-terminal tetrapeptide sequence
13. Opiate agonists inhibit neurogenic plasma extravasation in the rat
14. On the origin from the spinal cord of vasodilator fibres of the hind limb and on the nature of these fibres
15. Inhibition of axon reflex vasodilatation by topically applied capsaicin
16. Substance P: Release on trigeminal nerve stimulation, effects in the eye
17. Biphasic time-course of capsaicin-induced substance P depletion: Failure to correlate with thermal analgesia in the rat
18. Sensory and autonomic innervation of non-hairy and hairy human skin. An immunohistochemical study
19. Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle
20. Inflammatory oedema induced by synergism between calcitonin generelated peptide (CGRP) and mediators of increased vascular permeability
21. Calcitonin gene-related peptide is a potent vasodilator
22. Potent vasodilator activity of calcitonin gene-related peptide in human skin
23. Die Pathogenese der trophischen Gewebsschaden nach der Nervenverletzung
24. Morphine inhibits substance P release from peripheral sensory nerve endings
25. Vaso-dilator axon-reflexes
26. Thermal analgesia and substance P depletion induced by capsaicin in guinea-pigs
27. Depletion of primary afferent substance P by capsaicin and dihydrocapsaicin without altered thermal sensitivity in rats
28. Neuropeptides in sensory neurones
29. Novel pharmacology of substance K-binding sites: A third type of tachykinin receptor
30. In vitro release of substance P from spinal cord slices by capsaicin congeners
31. An attempt to demonstrate release of substance P from the tongue, skin and nose of dog and cat
32. Mechanisms of depletion of substance P by capsaicin
33. Purinergic nerves
34. Vascular and sensory responses of human skin to mild injury after topical treatment with capsaicin
35. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami
36. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: Evidence for opiate and non-opiate receptor participation
37. The nature and the distribution of afferent fibres provided with the axon reflex arrangement
38. Neonatal capsaicin and thermal nociception A paradox
39. Interactions of substance P with putative mediators of inflammation and ATP
40. The effect of putative peptide neurotransmitters on cutaneous vascular permeability in the rat
41. Local oedema and general excitation of cutaneous sensory receptors produced by electrical stimulation of the saphenous nerve in the rat
42. Inflammatory peptide in spinal cord: Evidence that the mediator of antidromic vasodilatation is not substance P
43. Plasma extravasation induced by dynorphin-(1–13) in rat skin
44. Effects of substance P antagonists on plasma extravasation induced by substance P and capsaicin in rat skin
45. Isolation of sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P
46. Amino-acid sequence of substance P
47. The participation of the nervous system in the inflammatory reaction
48. Autoradiographic localization and characterization of spinal cord substance P binding sites: High densities in sensory, autonomic, phrenic, and Onuf's motor nuclei
49. Correlation of mitochondrial swelling after capsaicin treatment and substance P and somatostatin immunoreactivity in small neurons of dorsal root ganglion in the rat
50. Substance P immunoreactive neurons following neonatal administration of capsaicin
51. Effects of peptides and non-peptides on isolated arterial smooth muscles Role of endothelium
52. Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins
53. Pharmacology and nerve endings
54. Co-existence of cholecystokinin-and substance P-like peptide in neurons of the dorsal root ganglia of the rat
55. Localization of substance P-immunoreactive nerve fibers in the human digital skin
56. Neurokinin A-like immunoreactivity in rat primary sensory neurons; coexistence with substance P
57. Peptides and histamine release from rat peritoneal mast cells
58. Laminar localization of the sites of release of immunoreactive substance P in the dorsal horn with antibody-coated microelectrodes
59. Release of histamine by substance P
60. The action potential in fibres of slow conduction in spinal roots and somatic nerves
61. Occurrence of tachykinins (Physalemin-or substance P-like peptides) in the amphibian skin and their actions on smooth muscle preparations
62. Untersuchungen uber Substanz P die atropinfeste darmerregende und gefasserweiternde Substanz aus Darm und Hirn
63. An unidentified depressor substance in certain tissue extracts
64. Stress, symmetry, and psoriasis: Possible role of neuropeptides
65. Effects of neonatal capsaicin administration on the nociceptive response of the rat to mechanical and chemical stimuli
66. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat
67. Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide
68. Capsaicin and sensory neurones—A review
69. Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK33-824, β-endorphin and morphine
70. Chemical design of antagonists of substance P
71. Histamine release and vascular changes induced by neuropeptides
72. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin
73. The role of endothelium in the responses of vascular smooth muscle to drugs
74. Substance P-like immunoreactivity in nerves associated with the vascular system of guinea-pigs
75. Depressor substances in extracts of intestine
76. Capsaicin and nociception in the rat and mouse. Possible role of substance P
77. The spinal cord contains multiple factors causing plasma protein extravasation in the skin
78. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide
79. Substance P release from spinal cord slices by capsaicin
80. Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin
81. Effect of capsaicin pretreatment on capsaicinevoked release of immunoreactive somatostatin and substance P from primary sensory neurons
82. Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat
83. Capsaicin applied to peripheral nerve inhibits axoplasmic transport of substance P and somatostatin
84. Formation of a factor increasing vascular permeability during electrical stimulation of the saphenous nerve in rats
85. Antidromic action Part II stimulation of the peripheral nerves of the cat's hind foot
86. Contribution to the theory that substance P has a transmitter role in sensitive pathways
87. Evidence that substance P is a mediator of antidromic vasodilatation using somatostatin as a release inhibitor
88. Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurones of guinea pigs
89. Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea-pig
90. Neuropeptide regulation of the expression of immediate hypersensitivity
91. Further evidence for multiple tachykinin receptors
92. Flare and itch induced by substance P in human skin
93. Substance P antagonists release histamine from peritoneal mast cells
94. Peptidergic (neurotensin, VIP, substance P) nerve fibres in the skin. Immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus and inflammation
95. Activation of macrophages by substance P: Induction of oxidative burst and thromboxane release
96. Substance P: Binding properties and studies on cellular responses in guinea pig macrophages
97. Effects of capsaicin on nociceptive heat, pressure and chemical thresholds and on substance P levels in the rat
98. Effects of neonatal administration of capsaicin on nociceptive thresholds in the mouse and rat
99. The depolarising action of capsaicin on rat isolated sciatic nerve
100. Effect of capsaicin administration to neonatal rats on the substance P content of discrete CNS regions
101. The transmitter substance of sensory nerves
102. Neurogenic flare responses following topical application of capsaicin in humans
103. Immunoreactive substance P release from skin nerves in the rat by noxious thermal stimulation
104. Effects of substance P on functionally identified units in cat spinal cord
105. Substance P and pain: A possible relation in afferent transmission
106. The component of the dorsal root mediating vasodilatation and the Sherrington contracture
107. Immunohistochemical evidence of the presence of somatostatin, a powerful inhibitory peptide, in some primary sensory neurons
108. Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons
109. Substance P: Localization in the central nervous system and in some primary sensory neurons
110. Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia Enkephalin and substance P
111. Peptidergic neurones
112. The capillary dilator substances in dry powders of spinal roots: A possible role of adenosine triphosphate in chemical transmission from nerve endings
113. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves
114. Further observations on substance P in degenerating nerve
115. On the transmitter responsible for antidromic vasodilatation in the rabbit's ear
116. Nociceptive threshold after neonatal capsaicin treatment
117. Distribution of capsaicin-sensitive nerve fibres containing immunoreactive substance P in cutaneous and visceral tissues of the rat
118. Tachykinins and calcitonin gene-related peptide in relation to peripheral functions of capsaicin-sensitive sensory neurons
119. Dual capsaicin effects on ureteric motility: Low dose inhibition mediated by calcitonin gene-related peptide and high dose stimulation by tachykinins?
120. Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig
121. Capsaicin induced release of multiple tachykinins (substance P Neurokinin A and eledoisin-like material) from guinea-pig spinal cord and ureter
122. Sub-cellular distribution of the substance P in the nervous tissues
123. Role of the nerve terminals in the mechanism of inflammatory reactions
124. Selective degeneration of chemosensitive primary sensory neurones induced by capsaicin Glial changes
125. Sensory neurotoxins: Chemically induced selective destruction of primary sensory neurons
126. Functional linkage between nociception and fluoride-resistant acid phosphatase activity in the Rolando substance
127. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin
128. The role of sensory nerve endings in neurogenic inflammation induced in human skin and in the eye and paw of the rat
129. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones
130. Chemosensitive pain fibres and inflammation
131. Direct evidence for an axonal site of action of capsaicin
132. Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P gastrin/CCK somatostatin VIP enkephalin neurotensin and 5-hydroxytryptamine
133. Opiate analgesics inhibit substance P release from rat trigeminal nucleus
134. Capsaicin-induced depletion of substance P from primary sensory neurones
135. Release of histamine from mast cells by vasoactive peptides
136. Mitochondrial alterations in the spinal ganglion cells of the rat accompanying the long-lasting sensory disturbance induced by capsaicin
137. Vascular responses of human skin to injection of substance P and mechanism of action
138. Neuromedin K: A novel mammalian tachykinin identified in porcine spinal cord
139. Sequence analysis of cloned cDNA for rat substance P precursor: Existence of a third substance P precursor
140. Identification of the unmyelinated sensory nerves which evoke plasma extravasation in response to antidromic stimulation
141. Responses of single nerve fibres to capsaicin applied to the skin
142. The role of substance P in the axon reflex in the rat
143. Intrathecal administration of substance P enhances cutaneous plasma protein extravasation in pentobarbital anaesthetized rats
144. Degranulation of mast cells following antidromic stimulation of cutaneous nerves
145. The involvement of mast cells in vasodilatation due to axon reflexes in injured skin
146. A pharmacological and histological investigation of the involvement of mast cells in cutaneous axon reflex vasodilatation
147. Novel neuropeptides neurokinin α and β isolated from porcine spinal cord
148. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones
149. Studies on the physiology of capillaries
150. Histamine in nervous tissue
151. Opiate receptor binding in primate spinal cord Distribution and changes after dorsal root section
152. Antidromic action Part II Stimulation of the peripheral nerves of the cat's hind foot
153. On reflex action from sympathetic ganglia
154. Neonatal capsaicin is not a specific neurotoxin for sensory C-fibres or small dark cells of rat dorsal root ganglia
155. Coexistence of peptide immunoreactivity in sensory neurons of the cat
156. Neuropeptides in physiologically identified mammalian sensory neurones
157. A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation
158. The possible existence of multiple receptors for substance P
159. Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P
160. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation
161. Zur Frage der zentralen Ubertragung afferenter Impulse. III. Mitteilung. Das Vorkommen und die Bedeutung der Substanz P in den dorsalen Wurzeln des Ruckenmarks
162. Sir Thomas Lewis's nocifensor system, histamine and substance P-containing primary afferent nerves
163. Time course of capsaicin-induced functional impairments in comparison with changes in neuronal substance P content
164. Opioid control of the function of primary afferent substance P fibres
165. Substance P in peripheral sensory processes
166. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation
167. 5] enkephalinamide
168. Substance P and sensory nerve endings
169. Calcitonin gene-related peptide acts within the central nervous system to inhibit gastric acid secretion
170. Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis
171. Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves
172. The nocifensor system of nerves and its reactions
173. The nocifensor system of nerves and its reactions
174. Pain derived from the skin and the mechanism of its production
175. Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs
176. Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin
177. Multiple tachykinins in capsaicin-sensitive afferents: occurrence, release and biological effects with special reference to irritation of the airways
178. Capsaicin pretreatment inhibits the flare component of the cutaneous allergic reaction in man
179. Regional distribution of kassinin-like immunoreactivity in rat central and peripheral tissues and the effect of capsaicin
180. Endothelial contraction induced by histamine-type mediators. An electron microscopic study
181. Capsaicinoid-induced local and systemic antinociception without substance P depletion
182. Neuromedin L: A novel mammalian tachykinin identified in porcine spinal cord
183. Les fonctions vaso-motrices des racines posterieures
184. Pharmacology of the neurogenic oedema response to electrical stimulation of the saphenous nerve in the rat
185. Purinergic mechanisms in antidromic vasodilatation and neurogenic inflammation
186. Neurotoxic action of capsaicin on spinal substance P neurons
187. Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor
188. Substance K: A novel mammalian tachykinin that differs from substance P in its pharmacological profile
189. Localization of substance P-like immunoreactivity in the mouse gut
190. Regional distribution of substance P, neurokinin α and neurokinin β in rat spinal cord, nerve roots and dorsal root ganglia, and the effects of dorsal root section or spinal transection
191. Release of substance P-like immunoreactivity from the dental pulp
192. Electrophysiological and neurochemical evidence for substance P as a transmitter of primary sensory neurons
193. Distribution of bombesin, somatostatin, substance-P and vasoactive intestinal polypeptide in feline and porcine skin
194. Depletion by capsaicin of substance P-immunoreactivity and acetyl-cholinesterase activity from nerve fibres in the guinea-pig heart
195. 5-hydroxytryptamine and tissue mast cells
196. Modulation of lymphocyte function by sensory neuropeptides
197. Substance P recognition by a subset of human T lymphocytes
198. Studies on substance P. Purification, occurrence and biological actions
199. The effect of capsaicin application to a peripheral nerve on impulse conduction in functionally identified afferent nerve fibres
200. Dichotomizing peripheral fibres revealed by intracellular recording from rat sensory neurones
201. Use of substance P fragments to differentiate substance P receptors of different tissues
202. On the actions of substance P, somatostatin and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin
203. Some effects of calcitonin gene-related peptide in human skin and on histamine release
204. The substance P receptor on rat mast cells and in human skin
205. Radioimmunoassay for substance P
206. Effect of capsaicin on neuropeptides in areas of termination of primary sensory neurones
207. Effect of substance P in cat dorsal horn neurones activated by noxious stimuli
208. Serum vasoconstrictor (serotonin) V The presence of creatinine in the complex A proposed study of the vasoconstrictor principle
209. Receptors for substance P. III Classification by competitive antagonists
210. Bradykinin a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin
211. Inhibition of antidromic and substance P-induced vasodilatation by a substance P antagonist
212. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
213. Neurophysiological effects of capsaicin
214. Potent peripheral and splanchnic vasodilator peptide from normal gut
215. Antagonism between Lioresal and substance P in rat spinal cord
216. Neurotransmitter candidates of somatosensory primary afferent fibres
217. Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge
218. Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices
219. Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release
220. Sensory substance P-innervation of the urinary bladder: Possible site of action of capsaicin in causing urine retention in rats
221. Substance P-like immunoreactivity in the intramural nerve plexuses of the guinea-pig ureter: A light and electron microscopical study
222. + current in dissociated smooth muscle cells
223. 3H-muscimol binding sites in rat dorsal spinal cord after neonatal capsaicin treatment
224. Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurones and sensory ganglia of the rat
225. Suggestive evidence for a functional unit between mast cells and substance P fibres in the rat diaphragm and mesentery
226. Peripheral opioid receptors located on the rat saphenous nerve
227. Differential effects of vasoactive intestinal peptide, substance P and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen
228. Autoradiographic analysis of receptors on vascular endothelium
229. Untersuchung uber die Geffasserwurzeln des Ischiadicus
230. The participation of the nervous system in the inflammatory reaction
231. The local efferent function of capsaicin sensitive C-nociceptors
232. Capsaicin type pungent agents producing pyrexia
233. Capsaicin and neurogenic inflammation: History and early findings
234. Functional and fine structural characteristics of the sensory neuron blocking effect of capsaicin
235. Regional distribution of substance P in the spinal cord and nerve roots of the cat and the effect of dorsal root section
236. Vasoactive effects of substance P on isolated rabbit pulmonary artery
237. Neuropeptide K: Isolation, structure and biological activities of a novel brain tachykinin
238. Capsaicin-evoked release of substance P from primary sensory neurons
239. The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP)
240. Synthesis of substance P
241. The mechanism of enhancement of the neurogenic oedema response by baclofen
242. Are the proposed substance P receptor sub-types, substance P receptors?
243. Altered excitability of afferent C-fibres of the rat distal to a nerve site exposed to capsaicin
244. Afferent C-fibres in rats after neonatal capsaicin treatment
245. Release of substance P from peripheral nerve terminals following electrical stimulation of the sciatic nerve
246. Histamine involvement in the local and systemic microvascular effects produced by intradermal substance P
247. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo
248. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by substance P
249. The tachykinins: A family of peptides with a brood of ‘receptors’
250. The axon reflex flare
251. Neurogenic inflammation
252. Modulation of immunity and hypersensitivity by sensory neuropeptides
253. Substance P-A putative mediator of antidromic vasodilation
254. Role of tachykinins in neurogenic inflammation